During the past decade, Cliniques Universitaires Saint-Luc; Pharmacy conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cliniques Universitaires Saint-Luc; Pharmacy" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cliniques Universitaires Saint-Luc; Pharmacy" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Ulcerative Colitis" (2 trials) and "Paroxysmal Nocturnal Hemoglobinuria" (1 trials). Many other conditions were trialed in "Cliniques Universitaires Saint-Luc; Pharmacy" in a lesser frequency.

Most popular intervention types in "Cliniques Universitaires Saint-Luc; Pharmacy" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Crovalimab" (1 trials), "Eculizumab" (1 trials) and "Infliximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cliniques Universitaires Saint-Luc; Pharmacy" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Cliniques Universitaires Saint-Luc; Pharmacy". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cliniques Universitaires Saint-Luc; Pharmacy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cliniques Universitaires Saint-Luc; Pharmacy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".